LINDA HALE: Open Payments
NPI 1588791909 · WILLIAMSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$629 in 39 payments from 11 companies in 2025. Trend: 2023 $411 · 2024 $564 · 2025 $629
Food & beverage: $584Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $136 |
| Lilly USA, LLC | 4 | $89 |
| Axsome Therapeutics, Inc. | 4 | $84 |
| Exact Sciences Corporation | 3 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Alnylam Pharmaceuticals Inc. | 3 | $47 |
| Abbott Laboratories | 1 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Novo Nordisk Inc | 2 | $33 |
| AtriCure, Inc. | 1 | $27 |
Products named: Auvelity, QULIPTA, VRAYLAR, Kerendia, GIVLAARI, The Cologuard Plus Collection Kit, CARDIOMEMS, Ozempic.
Industry payments across KY — which companies pay providers there.
